- 专利标题： PROCESSES AND INTERMEDIATE FOR THE LARGE-SCALE PREPARATION OF 2,4,6-TRIFLUORO-N-[6-(1-METHYL-PIPERIDINE-4-CARBONYL)-PYRIDIN-2-YL]-BENZAMIDE HEMISUCCINATE
-
申请号： EP24174898.7申请日： 2020-07-06
-
公开(公告)号： EP4410784A2公开(公告)日： 2024-08-07
- 发明人: ABURUB, Aktham , COATES, David Andrew , FRANK, Scott, Alan , KERR, Mark, Steven , ROTHHAAR, Roger, Ryan , VAID, Radhe, Krishan
- 申请人： Eli Lilly and Company
- 申请人地址： US Indianapolis, IN 46285 Lilly Corporate Center
- 专利权人： Eli Lilly and Company
- 当前专利权人： Eli Lilly and Company
- 当前专利权人地址： US Indianapolis, IN 46285 Lilly Corporate Center
- 代理机构： Faggiani, Davide
- 优先权： US 1962871965P 2019.07.09
- 分案原申请号： 20751396.1 2020.07.06
- 主分类号： C07D401/06
- IPC分类号： C07D401/06
摘要：
The present invention provides 2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)-2-pyridyl]benzamide acetate salt, and/or pharmaceutical compositions thereof, and/or uses of lasmiditan acetate and formulations thereof in subcutaneous drug delivery.
信息查询
